Successful serial plasmapheresis for solar urticaria, a case report and literature review

被引:0
|
作者
Boontaveeyuwat, Einapak [1 ,2 ,3 ]
Willis, Fenella [4 ]
Fassihi, Hiva [1 ]
Sarkany, Robert P. E. [1 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, Photodermatol Unit, London SE19RT, England
[2] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Photodermatol Unit,Div Dermatol,Dept Med, Bangkok, Thailand
[3] Chulalongkorn Univ, Fac Med, Bangkok, Thailand
[4] St Georges Univ Hosp NHS Fdn Trust, Haematol Dept, London, England
关键词
Solar urticaria; plasmapheresis; photodermatosis; PLASMA-EXCHANGE; OMALIZUMAB;
D O I
10.1080/09546634.2024.2350229
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background/PurposeAmidst the emergence of new therapeutic options, traditional therapeutic plasmapheresis (TPE) used in diseases involving a toxic substance in the plasma, remains a viable alternative for cases of recalcitrant solar urticaria (SU). We emphasize the importance of documenting successful experience with repeated plasmapheresis to increase awareness amongst physicians and dermatologists regarding this effective treatment option.Material and MethodWe reported a case of recalcitrant SU that had not responded to a combination of H1-antihistamines, immunosuppressants, omalizumab and intravenous immunoglobulin. We introduced serial TPE, which involved two consecutive days of procedures for each course was introduced. We detailed the regimen and highlighted the clinical and objective benefits observed with multiple treatments. Additionally, we compared this to other plasmapheresis regimens and their treatment responses previously reported for solar urticaria.ResultsOur patient underwent serial TPE, totaling 42 procedures over five years. Following the last TPE session, phototesting showed a sustained prolongation of minimal urticating doses (MUDS), which exceeded the maximum tested doses across nearly all ultraviolet (UV) and visible light ranges, with the exception of the two short ultraviolet B (UVB) wavelengths. MUDs increased to 25 from 6 mj/cm2 at 307.5 +/- 5nm, and to 500 from 15 mj/cm2 at 320 +/- 10nm, before the initial TPE. In our review, we included five articles covering eight SU patients who received TPE. Of these, the five patients with positive intradermal tests responded particularly well immediately after treatment. However, the condition relapsed within two weeks in one patient and within two months in another. In contrast, the other three patients with negative intradermal tests, showed no significant benefits from the treatment. No serious side effects from TPE were reported amongst the patients.ConclusionsThis review underscores the efficacy of serial plasmapheresis procedures in treating refractory cases of SU, high3lighting the robust results observed.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Management of Pediatric Urticaria with Review of the Literature on Chronic Spontaneous Urticaria in Children
    Ben-Shoshan, Moshe
    Grattan, Clive E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (04) : 1152 - 1161
  • [42] Successful Treatment of Allopurinol-Induced Severe Skin Reactions with Double Filtration Plasmapheresis: A Case Report
    Xie, Pan
    Tao, Min
    Zhao, Hongwen
    Sheng, Yuxiu
    Qiu, Jun
    Xu, Yan
    Li, Huanna
    Wang, Huan
    Cao, Ge
    Ronco, Claudio
    Peng, Kanfu
    BLOOD PURIFICATION, 2020, 49 (06) : 748 - 752
  • [43] Successful treatment of anti-NMDA receptor encephalitis with early teratoma removal and plasmapheresis: A case report
    Gomes Ferreira, Monica
    Lapresa Alcalde, Victoria
    Garcia Sanchez, Maria Helena
    Hernandez Hernandez, Lourdes
    Sanchez, Maria Jose Doyague
    MEDICINE, 2018, 97 (31)
  • [44] THROMBOTIC THROMBOCYTOPENIC PURPURA COMPLICATING SYSTEMIC LUPUS-ERYTHEMATOSUS - CASE-REPORT AND LITERATURE-REVIEW FROM THE PLASMAPHERESIS ERA
    STRICKER, RB
    DAVIS, JA
    GERSHOW, J
    YAMAMOTO, KS
    KIPROV, DD
    JOURNAL OF RHEUMATOLOGY, 1992, 19 (09) : 1469 - 1473
  • [45] Solar urticaria treated successfully with intravenous high-dose immunoglobulin: a case report
    Correia, Isabel
    Silva, Joao
    Filipe, Paulo
    Gomes, Manuel
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2008, 24 (06) : 330 - 331
  • [46] Successful Treatment of Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid with Omalizumab: A Case Report and Review of the Literature
    Chen, Jiazhen
    Xu, Duanni
    He, Zezhi
    Ma, Shaoyin
    Liu, Jiahui
    Dai, Xiangnong
    Luo, Yuwu
    Ye, Xingdong
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 : 2865 - 2874
  • [47] Atypical Goodpasture's disease: a clinical case report and literature review
    Bulanova, M. L.
    Potapov, D. V.
    Bulanov, N. M.
    Lysenko , L. V.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (06) : 130 - 136
  • [48] Solar urticaria, a disease with many dark sides: is omalizumab the right therapeutic response? Reflections from a clinical case report
    De Martinis, Massimo
    Sirufo, Maria Maddalena
    Ginaldi, Lia
    OPEN MEDICINE, 2019, 14 (01): : 403 - 406
  • [49] Omalizumab in cold urticaria in children: Retrospective case series of 13 patients, review of the literature
    Briand, C.
    Tetart, F.
    Soria, A.
    Staumont-Salle, D.
    Sterling, B.
    Boralevi, F.
    Lakkis, F. Castelain
    Du-Thanh, A.
    Raison-Peyron, N.
    Chiaverini, C.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2021, 148 (04): : 269 - 271
  • [50] Effective treatment of different phenotypes of chronic urticaria with omalizumab: Case reports and review of literature
    Kasperska-Zajac, A.
    Jarzab, J.
    Zerdzinska, A.
    Bak, K.
    Grzanka, A.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2016, 29 (02) : 320 - 328